This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: The Innovations of Henri S. Lichenstein
Introduction
Henri S. Lichenstein is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of biotechnology, particularly in the development of anti-inflammatory treatments. His work has the potential to impact various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Henri S. Lichenstein holds a patent for "Anti-inflammatory CD14 polypeptides." This invention relates to anti-inflammatory polypeptides comprising soluble CD14 related polypeptides that have amino acids at positions 7-10 differing from the native sequence or having amino acids 1-14 deleted. This patent highlights his commitment to advancing medical science through innovative solutions.
Career Highlights
Lichenstein is currently associated with Amgen Inc., a leading biotechnology company. His role at Amgen allows him to collaborate with other experts in the field and contribute to groundbreaking research and development. His work is instrumental in pushing the boundaries of what is possible in biotechnology.
Collaborations
Henri has worked alongside talented colleagues such as Samuel D. Wright and Shao-Chieh Juan. These collaborations enhance the research environment and foster innovation, leading to significant advancements in their respective fields.
Conclusion
Henri S. Lichenstein exemplifies the spirit of innovation in biotechnology. His contributions, particularly through his patent on anti-inflammatory polypeptides, demonstrate the vital role inventors play in improving healthcare solutions. His ongoing work at Amgen Inc. continues to pave the way for future advancements in the industry.